Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trialsArthroscopy. 2014 Aug;30(8):987-96
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Data from 14 Level I or Level II randomized controlled trials (N=4726) was gathered in this meta-analysis. The aim of this study was to assess the efficacy of low-molecular-weight heparin venous thromboprophylaxis versus placebo/no treatment in non-major orthopaedic patients with transient reduced mobility. Findings indicated significant risk reduction of thromboembolic events with prophylactic lo...
Join the Conversation
Please Login or Join to leave comments.